APPROVALS ANALYSIS: PMAs Remain On Track For Big Year Despite Slow Month
This article was originally published in Clinica
The total number of premarket approvals and major premarket approval supplements approved by the US FDA in 2015 so far are already well ahead of the totals in 2014 or 2013, Clinica’s Approval Tracker shows.
You may also be interested in...
The FAST 01 feasibility trial is evaluating a modification to Varian’s ProBeam particle accelerator that enables ultra-high dose radiation to treat cancer.
Data from the EARLY AF First, Cryo-FIRST and STOP AF trials show cryoablation is a better option than drugs for patients with symptomatic atrial fibrillation.
In this week’s podcast, Marion Webb reviews her interview with Glooko CEO Russ Johannesson and Reed Miller explains how Boston Scientific is restructuring its transcatheter aortic valve business.